Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection

AIDS Research and Human Retroviruses

Volumn 16, Issue 5, 2000, Pages 403-413

  Markert, M Louise ^a   Hicks, Charles B ^a   Bartlett, John A ^a   Les Harmon, J ^a   Hale, Laura P ^a   Greenberg, Michael L ^a   Ferrari, Guido ^a   Ottinger, Janet ^a   Boeck, Andreas ^b   Kloster, Amy L ^a   McLaughlin, Tanya M ^a   Bleich, Karen B ^a   Ungerleider, Ross M ^a   Lyerly, H Kim ^a   Wilkinson, William E ^a   Rousseau, Franck S ^c   Heath Chiozzi, Margo E ^d   Leonard, John M ^d   Haase, Ashley T ^e   Shaw, George M ^f   Bucy, R Pat ^g   Douek, Daniel C ^h   Koup, Richard A ^h   Haynes, Barton F ^a   Bolognesi, Dani P ^a,i   Weinhold, Kent J ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c GLAXOSMITHKLINE   (United States)

^d ABBOTT LABORATORIES   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g University of Alabama at Birmingham   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ Trimeris Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; KEYHOLE LIMPET HEMOCYANIN; LAMIVUDINE; RITONAVIR; T LYMPHOCYTE RECEPTOR; TETANUS TOXOID; ZIDOVUDINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNIZATION; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS TRANSPLANTATION;

EID: 0034689657     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309061     Document Type: Article

References (35)

1. 1. Wolthers KC, Schuitemaker H, and Miedema F: Rapid CD4+ T-cel turnover in HIV-1 infection: A paradigm revisted. Immunol Today 1998;19:44-48.
2. 2. Clerici M, Stocks NI, Zajac RA, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989;84: 1892-1899.
3. 3. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, and Terstappen LW: Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol 1993;150:1105-1121.
4. 4. Connors M, Kovacs JA, Krevat S, et al.: HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997;3:533-540.
5. 5. Pannetier C, Even J, and Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
6. 6. Douek DC, McFarland RD, Keiser PH, et al.: Changes in thymic function with age and during the treatment of HIV infection. Nature (London) 1998;396:690-695.
7. 7. Li TS, Tubiana R, Katlama C, Calvez V, Mohand HA, and Autran B: Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-1686.
8. 8. Autran B, Carcelain G, Li TD, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
9. 9. Kelleher AD, Carr A, Zaunders J, and Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV) infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996;173:321-329.
10. 10. Lederman MM, Connick E, Landay A, et al.: Immunologic responses associated with 12 weeks of combination antiretorivral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinicial Trials Group Protocol 315. J Infect Dis 1998;178:70-79.
11. 11. Meyers A, Pepe N, Cranley W, and McCarten K: Decreased thymus size on chest radiography: A sign of pediatric human immunodeficiency virus infection? Pediatrics 1992;90:99-102.
12. 12. Welch K: The thymus in AIDS. Am J Clin Pathol 1986;85:531. [Letter to editor].
13. 13. Joshi VV and Oleske JM: Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. Arch Pathol Lab Med 1985;109:142-146.
14. 14. Falk S, Schmidts HL, Muller H, et al.: Autopsy findings in AIDS -a histopathological analysis of fifty cases. Klin Wochenschr 1987; 65:654-663.
15. 15. McCune MM, Loftus R, Schmidt D, et al.: High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
16. 16. Dwyer JM, Wood CC, McNamara J, and Kinder B: Transplantation of thymic tissue into patients with AIDS. Arch Intern Med 1987;147:513-517.
17. 17. Danner SA, Schuurman HJ, Lange J, et al.: Implantation of cultured thymic fragments in patients with acquired immunodeficiency syndrome. Arch Intern Med 1986;146:1133-1136.
18. 18. Dupuy JM, Gilmore N, Goldman HY, et al.: Thymic epithelial cell transplantation in patients with acquired immunodeficiency syndrome. Thymus 1991;17:205-218.
19. 19. Markert ML, Kostyu DD, Ward FE, et al.: Successful formation of a chimeric human thymus allograft following transplantation of partially HLA-matched postnatal thymus. J Immunol 1997;158: 998-1005.
20. 20. Kostyu DD, Pfohl J, Ward FE, Lee J, Marray A, and Amos DB: Rapid HLA-R oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays. Hum Immunol 1993;38:148-158.
21. 21. Amos DB, Pool P, and Grier J: HLA-A, HLA-B, HLA-C and HLA-DR. In Manual of Clinical Immunology (Rose NR and Friedman H, eds.). American Society for Microbiology, Washington, D.C., 1980, pp. 978-986.
22. 22. Palestine AG, Roberge F, Charous BL, Lane HC, Fauci AS, and Nussenblatt RB: The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J Clin Immunol 1985;5:115-121.
23. 23. Lane HC, Volkman DJ, Whalen G, and Fauci AS: In vitro antigen-induced, antigen-specific antibody production in man. J Exp Med 1981;154:1043-1057.
24. 24. Hornbeck P: Antibody detection and preparation. In Current Protocols in Immunology (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, eds.). John Wiley & Sons, New York, 1997, pp. 1:2.1.2-2.1.22.
25. 25. Haase AT, Henry K, Zupancic M, et al.: Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274:985-989.
26. 26. Anderson P, Nagler-Anderson C, O'Brian C, et al.: A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990;144:574-582.
27. 27. Key G, Becker MHG, Baron B, et al.: New Ki-67-equivalent murine monoclonal antibodies (Mib 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-636.
28. 28. Haynes BF, Hale LP, Weinhold KJ, Patel DD, Liao HX, Bressler PB, Jones DM, Demarest JF, Gebhard-Mitchell K, Haase AT, and Bartlett JA: Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 1999;103:453-460.
29. 29. Markert ML, Boeck A, Hale LP, et al.: Thymus transplantation in complete DiGeorge syndrome. N Engl J Med 1999;341:1180-1189.
30. 30. Gulick RM, Mellors JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-739.
31. 31. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.
32. 32. Wong JK, Günthard HF, Havlir D, et al.: Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U.S.A. 1997;94:12574-12579.
33. 33. Huang KL, Ruben FL, Rinaldo CR, Kingsley L, Lyter DW, and Ho M: Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987;257: 2047-2048.
34. 34. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan ZH, Margolick J, and Clements ML: The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989;262:779-783.
35. 35. Steinhoff MC, Auerbach BS, Nelson KE, et al.: Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991;325:1837-1842.